Global Nonalcoholic Steatohepatitis (NASH) Market Survey and Trend Research 2018

September 2018 | 84 pages | ID: G418BBD41FAEN
99Strategy

Abstracts

Summary


This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Boehringer Ingelheim, Cerenis Therapeutics, Connexios Life Sciences, Genfit, Nimbus Therapeutics, Nimbus Therapeutics, Verva Pharmaceuticals, Viking Therapeutics, Astazeneca Plc, Galmed Pharmaceuticals, GENFIT SA, Gilead Science, Novo Nordisk, Immuron, Intercepts Pharmaceuticals, Enzo Biochem, Tobira Therapeutics etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Nonalcoholic Steatohepatitis (NASH) Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Boehringer Ingelheim (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Cerenis Therapeutics (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Connexios Life Sciences (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Genfit (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Nimbus Therapeutics (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Nimbus Therapeutics (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Verva Pharmaceuticals (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Viking Therapeutics (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Astazeneca Plc (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 Galmed Pharmaceuticals (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 GENFIT SA (Company Overview, Sales Data etc.)
4.12 Gilead Science (Company Overview, Sales Data etc.)
4.13 Novo Nordisk (Company Overview, Sales Data etc.)
4.14 Immuron (Company Overview, Sales Data etc.)
4.15 Intercepts Pharmaceuticals (Company Overview, Sales Data etc.)
4.16 Enzo Biochem (Company Overview, Sales Data etc.)
4.17 Tobira Therapeutics (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Nonalcoholic Steatohepatitis (NASH) Market 2012-2017, by Type, in USD Million
Table Global Nonalcoholic Steatohepatitis (NASH) Market 2012-2017, by Type, in Volume
Table Global Nonalcoholic Steatohepatitis (NASH) Market Forecast 2018-2023, by Type, in USD Million
Table Global Nonalcoholic Steatohepatitis (NASH) Market Forecast 2018-2023, by Type, in Volume
Table Boehringer Ingelheim Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cerenis Therapeutics Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Cerenis Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Connexios Life Sciences Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Connexios Life Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Genfit Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Genfit (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Nimbus Therapeutics Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Nimbus Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Nimbus Therapeutics Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Nimbus Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Verva Pharmaceuticals Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Verva Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Viking Therapeutics Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Viking Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Astazeneca Plc Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Astazeneca Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Galmed Pharmaceuticals Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Galmed Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GENFIT SA Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of GENFIT SA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gilead Science Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Gilead Science (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novo Nordisk Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Immuron Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Immuron (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Intercepts Pharmaceuticals Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Intercepts Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Enzo Biochem Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Enzo Biochem (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Tobira Therapeutics Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Tobira Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Nonalcoholic Steatohepatitis (NASH) Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Nonalcoholic Steatohepatitis (NASH) Sales Revenue Share, by Companies, in USD Million
Table Global Nonalcoholic Steatohepatitis (NASH) Sales Volume 2012-2017, by Companies, in Volume
Table Global Nonalcoholic Steatohepatitis (NASH) Sales Revenue Share, by Companies in 2017, in Volume
Table Nonalcoholic Steatohepatitis (NASH) Demand 2012-2017, by Application, in USD Million
Table Nonalcoholic Steatohepatitis (NASH) Demand 2012-2017, by Application, in Volume
Table Nonalcoholic Steatohepatitis (NASH) Demand Forecast 2018-2023, by Application, in USD Million
Table Nonalcoholic Steatohepatitis (NASH) Demand Forecast 2018-2023, by Application, in Volume
Table Global Nonalcoholic Steatohepatitis (NASH) Market 2012-2017, by Region, in USD Million
Table Global Nonalcoholic Steatohepatitis (NASH) Market 2012-2017, by Region, in Volume
Table Nonalcoholic Steatohepatitis (NASH) Market Forecast 2018-2023, by Region, in USD Million
Table Nonalcoholic Steatohepatitis (NASH) Market Forecast 2018-2023, by Region, in Volume

List Of Figures

LIST OF FIGURES

Figure Nonalcoholic Steatohepatitis (NASH) Industry Chain Structure
Figure Global Nonalcoholic Steatohepatitis (NASH) Market Growth 2012-2017, by Type, in USD Million
Figure Global Nonalcoholic Steatohepatitis (NASH) Market Growth 2012-2017, by Type, in Volume
Figure Global Nonalcoholic Steatohepatitis (NASH) Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Nonalcoholic Steatohepatitis (NASH) Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region